CIK 0001935979
- Large accelerated filer
Biohaven Ltd.
Sign in to watch- Ticker
- BHVN
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Virgin Islands, British
- Entity type
- Operating
- Phone
- +1 203-404-0410
- Business address
- 215 CHURCH STREET, NEW HAVEN, CT, 06510
- Former names
- Biohaven Research Ltd.
- 4 Open-market buy Director bought 17,817 shares at $22.57 ($402,094)
- 4 Open-market buy Director bought 50,000 shares at $18.44 ($922,180)
- 4 Open-market buy Director bought 100,000 shares at $19.78 ($1,978,430)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4/A Open-market buy Director bought 3,709,819 shares at $10.50 ($38,953,100)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Chief Executive Officer bought 25,800 shares at $15.97 ($411,995)
- 4 Open-market buy Chief Executive Officer bought 141,930 shares at an average $14.84 ($2,105,772)
- 4 Open-market buy Director bought 200,000 shares at $10.50 ($2,100,000)
- 4 Open-market buy Chief Executive Officer bought 853,380 shares at $10.50 ($8,960,490)
- 4 Open-market buy Director bought 3,900,000 shares at $10.50 ($40,950,000)
- 4 Open-market buy Chief Financial Officer bought 142,857 shares at $10.50 ($1,499,999)
- 4 Open-market buy Director bought 9,523 shares at $10.50 ($99,992)
- 4/A Other acquisition Chief Executive Officer acquired 0 shares (other)
Page 5 of 7 · 130 filings